Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-07-15 Sale | 2022-07-19 4:40 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 46,034 | $30 | $1,381,020 | 103,855 (Direct) | View |
2022-07-13 Sale | 2022-07-15 4:40 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 1,916 | $30 | $57,480 | 149,889 (Direct) | View |
2022-05-11 Sale | 2022-05-13 4:37 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $41.9 | $222,050 | 151,805 (Direct) | View |
2022-04-11 Sale | 2022-04-13 4:36 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $62.77 | $332,705 | 157,105 (Direct) | View |
2022-04-04 Sale | 2022-04-06 4:49 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 7,950 | $60 | $477,000 | 162,405 (Direct) | View |
2022-03-11 Sale | 2022-03-15 4:37 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $53.38 | $141,449 | 170,355 (Direct) | View |
2022-02-11 Sale | 2022-02-15 4:26 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $52.06 | $137,965 | 173,005 (Direct) | View |
2022-01-11 Sale | 2022-01-13 4:39 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $53.75 | $142,447 | 175,655 (Direct) | View |
2022-01-05 Sale | 2022-01-07 4:35 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $60 | $159,000 | 178,305 (Direct) | View |
2021-12-13 Sale | 2021-12-15 4:48 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $50.4 | $133,558 | 276,945 (Direct) | View |
2021-11-10 Sale | 2021-11-12 4:40 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 21,200 | $59.91 | $1,270,058 | 286,810 (Direct) | View |
2021-11-04 Sale | 2021-11-05 5:06 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 10,600 | $50 | $530,000 | 204,805 (Direct) | View |
2021-06-11 Sale | 2021-06-15 5:02 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $50.98 | $135,087 | 207,612 (Direct) | View |
2021-05-11 Sale | 2021-05-13 4:36 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $50 | $132,500 | 218,055 (Direct) | View |
2021-04-12 Sale | 2021-04-14 4:43 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $60 | $318,026 | 206,192 (Direct) | View |
2021-03-11 Sale | 2021-03-15 4:43 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $64.48 | $341,750 | 201,496 (Direct) | View |
2021-02-11 Sale | 2021-02-16 5:47 pm | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $64.91 | $344,017 | 173,596 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-07-15 Exercise | 2022-07-19 4:40 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 46,034 | $0.3 | 103,855 (Direct) | View |
2022-07-15 Exercise | 2022-07-19 4:40 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 46,034 | $0 | 103,855 (Direct) | View |
2022-07-13 Exercise | 2022-07-15 4:40 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 1,916 | $0.3 | 149,889 (Direct) | View |
2022-07-13 Exercise | 2022-07-15 4:40 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 1,916 | $0 | 149,889 (Direct) | View |
2022-06-14 Exercise | 2022-06-14 6:57 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 9,400 | $0.3 | 151,805 (Direct) | View |
2022-06-14 Exercise | 2022-06-14 6:57 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 9,400 | $0 | 151,805 (Direct) | View |
2022-05-11 Exercise | 2022-05-13 4:37 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0.3 | 151,805 (Direct) | View |
2022-05-11 Exercise | 2022-05-13 4:37 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0 | 151,805 (Direct) | View |
2022-04-11 Exercise | 2022-04-13 4:36 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0.3 | 157,105 (Direct) | View |
2022-04-11 Exercise | 2022-04-13 4:36 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0 | 157,105 (Direct) | View |
2022-04-04 Exercise | 2022-04-06 4:49 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 7,950 | $0.3 | 162,405 (Direct) | View |
2022-04-04 Exercise | 2022-04-06 4:49 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 7,950 | $0 | 162,405 (Direct) | View |
2022-03-11 Exercise | 2022-03-15 4:37 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0.3 | 170,355 (Direct) | View |
2022-03-11 Exercise | 2022-03-15 4:37 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0 | 170,355 (Direct) | View |
2022-02-11 Exercise | 2022-02-15 4:26 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0.3 | 173,005 (Direct) | View |
2022-02-11 Exercise | 2022-02-15 4:26 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0 | 173,005 (Direct) | View |
2022-01-21 Option Award | 2022-01-25 4:14 pm | N/A 2032-01-20 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 50,000 | $0 | 50,000 (Direct) | View |
2022-01-11 Exercise | 2022-01-13 4:39 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0.3 | 175,655 (Direct) | View |
2022-01-11 Exercise | 2022-01-13 4:39 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0 | 175,655 (Direct) | View |
2022-01-05 Exercise | 2022-01-07 4:35 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0.3 | 178,305 (Direct) | View |
2022-01-05 Exercise | 2022-01-07 4:35 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0 | 178,305 (Direct) | View |
2021-12-13 Exercise | 2021-12-15 4:48 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0.3 | 276,945 (Direct) | View |
2021-12-13 Exercise | 2021-12-15 4:48 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0 | 276,945 (Direct) | View |
2021-11-10 Exercise | 2021-11-12 4:40 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 21,200 | $0.3 | 286,810 (Direct) | View |
2021-11-10 Exercise | 2021-11-12 4:40 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 21,200 | $0 | 286,810 (Direct) | View |
2021-11-04 Exercise | 2021-11-05 5:06 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 10,600 | $0.3 | 204,805 (Direct) | View |
2021-11-04 Exercise | 2021-11-05 5:06 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 10,600 | $0 | 204,805 (Direct) | View |
2021-08-17 Exercise | 2021-08-18 5:21 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 1,293 | $0.3 | 85,700 (Direct) | View |
2021-08-17 Exercise | 2021-08-18 5:21 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 1,293 | $0 | 85,700 (Direct) | View |
2021-06-24 Exercise | 2021-06-25 6:29 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 6,500 | $0.3 | 85,700 (Direct) | View |
2021-06-24 Exercise | 2021-06-25 6:29 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 6,500 | $0 | 85,700 (Direct) | View |
2021-06-11 Exercise | 2021-06-15 5:02 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0.3 | 207,612 (Direct) | View |
2021-06-11 Exercise | 2021-06-15 5:02 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 2,650 | $0 | 207,612 (Direct) | View |
2021-05-11 Exercise | 2021-05-13 4:36 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 3,150 | $0.3 | 218,055 (Direct) | View |
2021-05-13 Exercise | 2021-05-13 4:36 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 6,220 | $0.11 | 218,055 (Direct) | View |
2021-05-11 Exercise | 2021-05-13 4:36 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 9,370 | $0 | 218,055 (Direct) | View |
2021-04-12 Exercise | 2021-04-14 4:43 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0.3 | 206,192 (Direct) | View |
2021-04-12 Exercise | 2021-04-14 4:43 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0 | 206,192 (Direct) | View |
2021-04-01 Exercise | 2021-04-02 4:32 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 9,996 | $0.11 | 71,187 (Direct) | View |
2021-04-01 Exercise | 2021-04-02 4:32 pm | N/A 2027-02-05 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 9,996 | $0 | 71,187 (Direct) | View |
2021-03-11 Exercise | 2021-03-15 4:43 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0.3 | 201,496 (Direct) | View |
2021-03-11 Exercise | 2021-03-15 4:43 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0 | 201,496 (Direct) | View |
2021-02-26 Exercise | 2021-03-01 4:54 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 33,200 | $0.11 | 71,187 (Direct) | View |
2021-02-26 Exercise | 2021-03-01 4:54 pm | N/A 2027-02-05 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 33,200 | $0 | 71,187 (Direct) | View |
2021-02-11 Exercise | 2021-02-16 5:47 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0.3 | 173,596 (Direct) | View |
2021-02-11 Exercise | 2021-02-16 5:47 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 5,300 | $0 | 173,596 (Direct) | View |
2021-01-10 Option Award | 2021-01-12 5:21 pm | N/A 2031-01-09 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 42,250 | $0 | 42,250 (Direct) | View |
2020-04-07 Option Award | 2020-04-08 9:00 pm | N/A 2030-04-06 | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 241,222 | $0 | 241,222 (Direct) | View |
Ownership | 2020-04-07 7:32 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lachey Jennifer Chief Scientific Officer | 0 | $0 | 321,846 (Direct) | View |